WHO recommends R21/Matrix-M vaccine for malaria prevention

Serum Life Science Europe GmbH (SLS Europe) is delighted to announce the recommendation by the World Health Organization (WHO) for the novel R21/Matrix-M Malaria Vaccine for prevention of malaria in children. This recommendation is an exciting milestone and was achieved by the joint global efforts of SLS Europe (former VPM), Serum Institute of India (SII) and Oxford University. READ MORE.